Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Systemic high-dose intravenous methotrexate in patients with central nervous system metastatic breast cancer.

Bazan F, Dobi E, Royer B, Curtit E, Mansi L, Menneveau N, Paillard MJ, Meynard G, Villanueva C, Pivot X, Chaigneau L.

BMC Cancer. 2019 Nov 1;19(1):1029. doi: 10.1186/s12885-019-6228-6.

2.

[Patient Journey in Schizophrenia - Lessons of a Hungarian Survey].

Herold R, Kurimay T, Dobi E, Kun E, Fehér L.

Psychiatr Hung. 2018;33(3):243-265. Hungarian.

PMID:
30426931
3.

[Prevalence and management of pain in patients with metastatic cancer in Franche-Comté].

Dénommé F, Kroemer M, Montcuquet P, Nallet G, Thiery-Vuillemin A, Bazan F, Mouillet G, Villanueva C, Demarchi M, Stein U, Almotlak H, Chaigneau L, Curtit E, Meneveau N, Maurina T, Dobi E, Hon TN, Cals L, Mansi L, Verlut C, Pana-Katatali H, Caubet M, Paillard MJ, Limat S, Pivot X, Nerich V.

Bull Cancer. 2016 Oct;103(10):849-860. doi: 10.1016/j.bulcan.2016.08.007. Epub 2016 Sep 29. French.

PMID:
27692731
4.

Prognostic value of baseline seric Syndecan-1 in initially unresectable metastatic colorectal cancer patients: a simple biological score.

Jary M, Lecomte T, Bouché O, Kim S, Dobi E, Queiroz L, Ghiringhelli F, Etienne H, Léger J, Godet Y, Balland J, Lakkis Z, Adotevi O, Bonnetain F, Borg C, Vernerey D.

Int J Cancer. 2016 Nov 15;139(10):2325-35. doi: 10.1002/ijc.30367. Epub 2016 Aug 13.

5.

Carboplatin-etoposide combination chemotherapy in metastatic castration-resistant prostate cancer: A retrospective study.

Caubet M, Dobi E, Pozet A, Almotlak H, Montcuquet P, Maurina T, Mouillet G, N'guyen T, Stein U, Thiery-Vuillemin A, Fiteni F.

Mol Clin Oncol. 2015 Nov;3(6):1208-1212. Epub 2015 Aug 31.

6.

[Efficacy, safety and cost of eribulin in patients with metastatic breast cancer].

Paillard MJ, Curtit E, Dobi E, Mansi L, Bazan F, Villanueva C, Chaigneau L, Montcuquet P, Meneveau N, Thiery-Vuillemin A, Nerich V, Pivot X.

Bull Cancer. 2015 Sep;102(9):737-48. doi: 10.1016/j.bulcan.2015.03.021. Epub 2015 May 26. French.

PMID:
26022285
7.

In the era of genomics, should tumor size be reconsidered as a criterion for neoadjuvant chemotherapy?

Pivot X, Mansi L, Chaigneau L, Montcuquet P, Thiery-Vuillemin A, Bazan F, Dobi E, Sautiere JL, Rigenbach F, Algros MP, Butler S, Jamshidian F, Febbo P, Svedman C, Paget-Bailly S, Bonnetain F, Villanueva C.

Oncologist. 2015 Apr;20(4):344-50. doi: 10.1634/theoncologist.2014-0198. Epub 2015 Mar 20.

8.

Prognostic value of angiopoietin-2 for death risk stratification in patients with metastatic colorectal carcinoma.

Jary M, Vernerey D, Lecomte T, Dobi E, Ghiringhelli F, Monnien F, Godet Y, Kim S, Bouché O, Fratte S, Gonçalves A, Leger J, Queiroz L, Adotevi O, Bonnetain F, Borg C.

Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):603-12. doi: 10.1158/1055-9965.EPI-14-1059. Epub 2015 Jan 12.

9.

Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy.

Fiteni F, Jary M, Monnien F, Nguyen T, Beohou E, Demarchi M, Dobi E, Fein F, Cleau D, Fratté S, Nerich V, Bonnetain F, Pivot X, Borg C, Kim S.

BMC Gastroenterol. 2014 Aug 13;14:143. doi: 10.1186/1471-230X-14-143.

10.

[Economic assessment of the routine use of Oncotype DX® assay for early breast cancer in Franche-Comte region].

Nerich V, Curtit E, Bazan F, Montcuquet P, Villanueva C, Chaigneau L, Cals L, Méneveau N, Dobi E, Altmotlak H, Algros MP, Choulot MJ, Nallet G, Limat S, Mansion S, Pivot X.

Bull Cancer. 2014 Jul-Aug;101(7-8):681-9. doi: 10.1684/bdc.2014.1923. French.

PMID:
25091650
11.

Bifractionated CPT-11 with LV5FU2 infusion (FOLFIRI-3) in combination with bevacizumab: clinical outcomes in first-line metastatic colorectal cancers according to plasma angiopoietin-2 levels.

Kim S, Dobi E, Jary M, Monnien F, Curtit E, Nguyen T, Lakkis Z, Heyd B, Fratte S, Cléau D, Lamfichekh N, Nerich V, Guiu B, Demarchi M, Borg C.

BMC Cancer. 2013 Dec 27;13:611. doi: 10.1186/1471-2407-13-611.

12.

Long-term follow-up of patients with metastatic breast cancer treated by trastuzumab: impact of institutions.

Fiteni F, Villanueva C, Bazan F, Perrin S, Chaigneau L, Dobi E, Montcuquet P, Cals L, Meneveau N, Nerich V, Limat S, Pivot X.

Breast. 2014 Apr;23(2):165-9. doi: 10.1016/j.breast.2013.12.003. Epub 2013 Dec 22.

13.

Phase II study assessing lapatinib added to letrozole in patients with progressive disease under aromatase inhibitor in metastatic breast cancer-Study BES 06.

Villanueva C, Romieu G, Salvat J, Chaigneau L, Merrouche Y, N'guyen T, Vuillemin AT, Demarchi M, Dobi E, Pivot X.

Target Oncol. 2013 Jun;8(2):137-43. doi: 10.1007/s11523-013-0279-4. Epub 2013 Apr 23.

PMID:
23609057
14.

Safety and efficacy of cabazitaxel in the docetaxel-treated patients with hormone-refractory prostate cancer.

Calcagno F, Nguyen T, Dobi E, Villanueva C, Curtit E, Kim S, Montcuquet P, Kleinclauss F, Pivot X, Thiery-Vuillemin A.

Clin Med Insights Oncol. 2013;7:1-12. doi: 10.4137/CMO.S7256. Epub 2012 Dec 20.

15.

Impact of STAT3 phosphorylation on the clinical effectiveness of anti-EGFR-based therapy in patients with metastatic colorectal cancer.

Dobi E, Monnien F, Kim S, Ivanaj A, N'Guyen T, Demarchi M, Adotevi O, Thierry-Vuillemin A, Jary M, Kantelip B, Pivot X, Godet Y, Degano SV, Borg C.

Clin Colorectal Cancer. 2013 Mar;12(1):28-36. doi: 10.1016/j.clcc.2012.09.002. Epub 2012 Oct 17.

PMID:
23083634
16.

First-line bevacizumab plus taxane-based chemotherapy for metastatic breast cancer: cost-minimisation analysis.

Nerich V, Bazan F, Compagnat F, Dobi E, Villanueva C, Chaigneau L, Perrin S, Voidey A, Pivot X, Limat S.

Anticancer Res. 2012 Aug;32(8):3547-52.

PMID:
22843944
17.

Is extracapsular tumour spread a prognostic factor in patients with early breast cancer?

Dobi E, Bazan F, Dufresne A, Demarchi M, Villanueva C, Chaigneau L, Montcuquet P, Ivanaj A, Sautière JL, Maisonnette-Escot Y, Cals L, Algros MP, Woronoff AS, Pivot X.

Int J Clin Oncol. 2013 Aug;18(4):607-13. doi: 10.1007/s10147-012-0439-z. Epub 2012 Jul 5.

PMID:
22763660
18.

Specific anticancer treatments in the last 3 months of life: a French experience.

Viel E, Chaigneau L, Fanton E, Kalbacher E, Thiery-Vuillemnin A, Villanueva C, Dobi E, Curtit E, Almotlak H, Aubry R, Pivot X.

Support Care Cancer. 2013 Feb;21(2):405-12. doi: 10.1007/s00520-012-1529-1. Epub 2012 Jun 27.

PMID:
22736464
19.

Incidence and risk factors of anemia in patients with early breast cancer treated by adjuvant chemotherapy.

Chaumard N, Limat S, Villanueva C, Nerich V, Fagnoni P, Bazan F, Chaigneau L, Dobi E, Cals L, Pivot X.

Breast. 2012 Aug;21(4):464-7. doi: 10.1016/j.breast.2011.10.009. Epub 2011 Nov 26.

20.

Cabazitaxel: a novel microtubule inhibitor.

Villanueva C, Bazan F, Kim S, Demarchi M, Chaigneau L, Thiery-Vuillemin A, Nguyen T, Cals L, Dobi E, Pivot X.

Drugs. 2011 Jul 9;71(10):1251-8. doi: 10.2165/11591390-000000000-00000. Review. Erratum in: Drugs. 2011 Sep 10;71(13):1720.

PMID:
21770474
21.

[KIT and KIT: from biology to clinical use].

Curtit E, Mansi L, Viel E, Dobi E, Chaigneau L, Nguyen T, Pivot X, Blay JY, Kalbacher E.

Bull Cancer. 2012 Feb 1;99(2):191-7. doi: 10.1684/bdc.2011.1386. French.

22.

Duration: escalation study of oral etoposide with carboplatin in patients with varied solid tumors.

Thiery-Vuillemin A, Dobi E, Nguyen T, Royer B, Montange D, Maurina T, Kalbacher E, Bazan F, Villanueva C, Demarchi M, Chaigneau L, Ivanaj A, Pivot X.

Anticancer Drugs. 2010 Nov;21(10):958-62. doi: 10.1097/CAD.0b013e32833fc0be.

PMID:
20856105
23.

Immunofluorescence study of corneal wound healing after excimer laser anterior keratectomy in the monkey eye.

Malley DS, Steinert RF, Puliafito CA, Dobi ET.

Arch Ophthalmol. 1990 Sep;108(9):1316-22.

PMID:
2205186
24.

Corneal ablation by nanosecond, picosecond, and femtosecond lasers at 532 and 625 nm.

Stern D, Schoenlein RW, Puliafito CA, Dobi ET, Birngruber R, Fujimoto JG.

Arch Ophthalmol. 1989 Apr;107(4):587-92.

PMID:
2705929
25.

A new model of experimental choroidal neovascularization in the rat.

Dobi ET, Puliafito CA, Destro M.

Arch Ophthalmol. 1989 Feb;107(2):264-9.

PMID:
2464985
26.

Infrared laser surgery of the cornea. Studies with a Raman-shifted neodymium:YAG laser at 2.80 and 2.92 micron.

Stern D, Puliafito CA, Dobi ET, Reidy WT.

Ophthalmology. 1988 Oct;95(10):1434-41.

PMID:
3226691
27.
28.

Distribution of R-cognin in late embryonic and post-hatching chicken retina.

Dobi ET, Troccoli NM, Hausman RE.

Invest Ophthalmol Vis Sci. 1986 Mar;27(3):323-9.

PMID:
3512470
29.

Prostaglandin binding activity and myoblast fusion in aggregates of avian myoblasts.

Hausman RE, Dobi ET, Woodford EJ, Petrides S, Ernst M, Nichols EB.

Dev Biol. 1986 Jan;113(1):40-8.

PMID:
3943664
30.

Cognin distribution during differentiation of embryonic chick retinal cells in vitro.

Hausman RE, Katz MS, Dobi ET, Offermann J.

Int J Dev Neurosci. 1986;4(6):537-44.

PMID:
3455612

Supplemental Content

Support Center